INT

Innovative digital therapeutics program shows a reduction in hospitalizations and costs for heart failure patients

Retrieved on: 
Tuesday, November 21, 2023

A self-care app via smartphone or tablet where patients entered vital signs, weight, and heart failure symptoms; 2.

Key Points: 
  • A self-care app via smartphone or tablet where patients entered vital signs, weight, and heart failure symptoms; 2.
  • Digital therapeutics automated medication suggestions sent to the treating medical team; and 4.
  • Heart failure educational modules for patients – all based on Greybox Solutions' Takecare platform.
  • Preliminary results are available for the first 63 patients that completed the study, 32 intervention (INT) and 31 control (CTRL).

MediaTek's New Dimensity 8300 Chipset Redefines Premium Experiences in 5G Smartphones

Retrieved on: 
Tuesday, November 21, 2023

HSINCHU, Nov. 21, 2023 /PRNewswire/ -- MediaTek today announced the Dimensity 8300, a power-efficient chipset designed for premium 5G smartphones. As the newest SoC in the Dimensity 8000 lineup, this chipset combines generative AI capabilities, low-power savings, adaptive gaming technology, and fast connectivity to bring flagship-level experiences to the premium 5G smartphone segment.

Key Points: 
  • HSINCHU, Nov. 21, 2023 /PRNewswire/ -- MediaTek today announced the Dimensity 8300, a power-efficient chipset designed for premium 5G smartphones.
  • As the newest SoC in the Dimensity 8000 lineup, this chipset combines generative AI capabilities, low-power savings, adaptive gaming technology, and fast connectivity to bring flagship-level experiences to the premium 5G smartphone segment.
  • With this powerful core configuration, the Dimensity 8300 boasts 20% faster CPU performance and 30% peak gains in power efficiency compared to the previous generation chipset.
  • Dimensity 8300 will power 5G devices launching in the global market before the end of 2023.

Florida Cancer Specialists & Research Institute Physicians Contribute to Immunotherapy Treatment Advances at Global Meeting

Retrieved on: 
Friday, November 3, 2023

FORT MYERS, Fla., Nov. 3, 2023 /PRNewswire/ -- Florida Cancer Specialists & Research Institute (FCS) physicians will present at the Society for Immunotherapy of Cancer Annual Meeting this week in San Diego.

Key Points: 
  • FORT MYERS, Fla., Nov. 3, 2023 /PRNewswire/ -- Florida Cancer Specialists & Research Institute (FCS) physicians will present at the Society for Immunotherapy of Cancer Annual Meeting this week in San Diego.
  • They will join stakeholders across the immune-oncology field worldwide to advance the science, discover breakthroughs and enhance education on cancer immunotherapy, which uses the body's own immune system to find, target and fight many forms of the disease.
  • "Immunotherapy is one of the most promising and successful treatment areas for cancer, even at the most advanced stages, said Lucio N. Gordan, MD , FCS President & Managing Physician.
  • "Through our robust and far-reaching clinical trials research program, FCS continues to contribute to cutting-edge research that is providing hope and improving outcomes for cancer patients worldwide."

Valens Semiconductor Launches First-to-Market High-Performance Single-Chip for Extension of USB3.2 Targeting Videoconferencing, Industrial and Medical Applications

Retrieved on: 
Wednesday, November 1, 2023

HOD HASHARON, Israel, Nov. 1, 2023 /PRNewswire/ -- Valens Semiconductor (NYSE: VLN), a premier provider of high-performance connectivity solutions for the audio-video and automotive markets, today announced the launch of the VS6320 chipset, a USB3.2 Gen1 extension solution. Valens Semiconductor's VS6320 provides a high-performance and efficient long-distance single-chip extension solution that addresses a critical need in the global videoconferencing, information technology (IT), industrial and medical markets. As planned, Valens will start shipping engineering samples to select customers in the fourth quarter of 2023, advancing the company's long-term vision to transform digital experiences worldwide with its extensive product portfolio.

Key Points: 
  • Valens Semiconductor's VS6320 provides a high-performance and efficient long-distance single-chip extension solution that addresses a critical need in the global videoconferencing, information technology (IT), industrial and medical markets.
  • USB3.2 has emerged as the go-to interface for devices used in videoconferencing and IT and is increasingly being used in industrial and medical applications.
  • I believe Valens Semiconductor is well positioned to capture a substantial share over the coming years also in this new untapped market of high-performance USB extension."
  • Valens Semiconductor's VS6320 provides extension of high-performance USB3.2 Gen1 peripherals at up to 100 meters/328 feet over category cable.

iFR and FFR are equally safe to diagnose and treat heart disease according to largest-ever analysis of new real-world, long-term data

Retrieved on: 
Thursday, October 26, 2023

iFR is an innovative pressure-derived index only offered by Philips that is used to assess coronary blockages during interventional procedures.

Key Points: 
  • iFR is an innovative pressure-derived index only offered by Philips that is used to assess coronary blockages during interventional procedures.
  • The analysis, “Long-term Safety of Revascularization Deferral Based on Instantaneous Wave-Free Ratio or Fractional Reserve,” compares patient outcomes using iFR and FFR in the diagnosis and treatment of heart disease.
  • The cumulative MACE risks for each group differentiated by 1.6% (iFR: 21.5%, FFR: 19.9%, HR 1.09 (95% CI: 0.90-1.33 at 5 years).
  • iFR is considered the Gold Standard for hyperemia-free physiologic assessment for measuring pressure in diagnostic and interventional procedures [1,4].

CHESAPEAKE ENERGY CORPORATION PROVIDES 2023 THIRD QUARTER EARNINGS CONFERENCE CALL INFORMATION

Retrieved on: 
Wednesday, October 18, 2023

OKLAHOMA CITY, Oct. 17, 2023 /PRNewswire/ -- Chesapeake Energy Corporation (NASDAQ:CHK) today announced that it will release its 2023 third quarter operational and financial results after market close on Tuesday, October 31, 2023.

Key Points: 
  • OKLAHOMA CITY, Oct. 17, 2023 /PRNewswire/ -- Chesapeake Energy Corporation (NASDAQ:CHK) today announced that it will release its 2023 third quarter operational and financial results after market close on Tuesday, October 31, 2023.
  • A conference call to discuss the results has been scheduled on Wednesday, November 1, 2023 at 9:00 am EST.
  • The telephone number to access the conference call is 1-888-317-6003 / INT TOLL: 1-412-317-6061, passcode 1010292.
  • Headquartered in Oklahoma City, Chesapeake Energy Corporation is powered by dedicated and innovative employees who are focused on discovering and responsibly developing leading positions in top U.S. oil and gas plays.

Merck Highlights Innovative Oncology Portfolio and Pipeline at ESMO Congress 2023 Underscoring Commitment to Advancing Cancer Research and Improving Patient Outcomes Across Multiple Stages of Disease

Retrieved on: 
Tuesday, October 10, 2023

The event will take place virtually and will be accessible via webcast.

Key Points: 
  • The event will take place virtually and will be accessible via webcast.
  • Safety and preliminary efficacy of the KRAS G12C inhibitor MK-1084 in solid tumors and in combination with pembrolizumab in NSCLC.
  • Pathologic response and exploratory analyses of neoadjuvant-adjuvant versus adjuvant pembrolizumab (PEM) for resectable stage IIIB-IV melanoma from SWOG S1801.
  • mRNA-4157 (V940) individualized neoantigen therapy + pembrolizumab vs pembrolizumab in high-risk resected melanoma: Clinical efficacy and correlates of response.

Ansys to Release Third Quarter 2023 Earnings on November 1, 2023

Retrieved on: 
Thursday, October 12, 2023

PITTSBURGH, Oct. 12, 2023 /PRNewswire/ -- ANSYS, Inc. (NASDAQ: ANSS) announced today that the Company expects to release its third quarter earnings on Wednesday, November 1, 2023, after the market closes.

Key Points: 
  • PITTSBURGH, Oct. 12, 2023 /PRNewswire/ -- ANSYS, Inc. (NASDAQ: ANSS) announced today that the Company expects to release its third quarter earnings on Wednesday, November 1, 2023, after the market closes.
  • We encourage participants to pre-register for the conference call using the enclosed link.
  • Callers who pre-register will be given a unique PIN to gain immediate access to the call, bypassing the live operator.
  • You will immediately receive an online confirmation, an email with the dial-in number, and a calendar invitation for the event.

EQS-News: Boditech Med and SphingoTec close Market Development Agreement to Boost Commercialization of Kidney Function Biomarker PenKid

Retrieved on: 
Thursday, August 31, 2023

In 2022, Boditech Med and SphingoTec closed a global licensing agreement to develop and offer the Proenkephalin A 119-159 (penKid) test on Boditech's automated immunoassay systems.

Key Points: 
  • In 2022, Boditech Med and SphingoTec closed a global licensing agreement to develop and offer the Proenkephalin A 119-159 (penKid) test on Boditech's automated immunoassay systems.
  • The current market development agreement aims at enhancing the commercialization of the upcoming assay for penKid and ultimately advancing AKI diagnostics.
  • Gangwon-do, Republic of Korea and Hennigsdorf/Berlin, Germany, August 31, 2023 - Boditech Med Inc. (“Boditech”) and SphingoTec GmbH (“SphingoTec”) today announced they have entered into a market development agreement (MDA), building on their previous licensing collaboration for the kidney function biomarker penKid.
  • The MDA solidifies the partnership between Boditech and SphingoTec, aiming to support the successful commercialization of the assay for the biomarker penKid on the AFIAS platforms.

Bradaverse Education obtains authorisation from Star Plus Legend to issue "Chouchou" card collection

Retrieved on: 
Tuesday, July 18, 2023

Bradaverse Education congratulates Star Plus Legend on the successful HKEX listing on July 13.

Key Points: 
  • Bradaverse Education congratulates Star Plus Legend on the successful HKEX listing on July 13.
  • Mr. Yip Kai Pong, Executive Director of Bradaverse Education (Left) and Mr. Alan Leung (Right), Director of UFO Interactive Group Limited, a subsidiary of Bradaverse Education congratulated Star Plus Legend Holdings Limited on the successful HKEX listing
    The two major businesses of Star Plus Legend are new retail and IP creation and operation.
  • In addition, Star Plus Legend has also created two-dimensional IPs, "Coach Liu" and "Vivi" for Liu Keng-hung and Vivi Wang respectively.
  • Star Plus Legend has many years of experience in IP and media content creation.